These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2432677)

  • 1. Effects of EACA on thrombin generation as measured by the chromagen S2238.
    Sloan IG; Firkin BG
    Thromb Res; 1986 Dec; 44(6):761-9. PubMed ID: 2432677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery.
    Slaughter TF; Faghih F; Greenberg CS; Leslie JB; Sladen RN
    Anesth Analg; 1997 Dec; 85(6):1221-6. PubMed ID: 9390584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and laboratory investigation of the effects of epsilon-aminocaproic acid on hemostasis.
    Green D; Ts'ao CH; Cerullo L; Cohen I; Ruo TI; Atkinson AJ
    J Lab Clin Med; 1985 Mar; 105(3):321-7. PubMed ID: 2982982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilizing effect of epsilon-aminocaproic acid on allergenic extracts.
    Van Hoeyveld EM; Stevens EA
    J Allergy Clin Immunol; 1985 Oct; 76(4):543-50. PubMed ID: 4056242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of some epsilon-aminocaproic acid derivatives on platelet responses.
    Bruzgo I; Tomasiak M; Stelmach H; Midura-Nowaczek K
    Acta Biochim Pol; 2004; 51(1):73-80. PubMed ID: 15094827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of epsilon aminocaproic acid on contractile properties and catecholamine content of rat carotid arteries.
    Barry KJ; Selland BA; Stein BM
    Surg Neurol; 1982 Apr; 17(4):273-8. PubMed ID: 7079951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of epsilon-aminocaproic acid distribution, elimination, and antifibrinolytic effects in normal subjects.
    Frederiksen MC; Bowsher DJ; Ruo TI; Henthorn TK; Ts'ao CH; Green D; Atkinson AJ
    Clin Pharmacol Ther; 1984 Mar; 35(3):387-93. PubMed ID: 6697646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the stabilizing effect of epsilon-aminocaproic acid by electrophoretic techniques and immunoblotting.
    Van Hoeyveld EM; Lejoly M; Walravens MJ; Stevens EA
    J Allergy Clin Immunol; 1989 Mar; 83(3):601-9. PubMed ID: 2926082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of alpha- and beta-thrombin by antithrombin-III, alpha 2-macroglobulin and alpha 1-proteinase inhibitor.
    Machovich R; Borsodi A; Blaskó G; Orakzai SA
    Biochem J; 1977 Nov; 167(2):393-8. PubMed ID: 74248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of substrate and fibrin polymerization inhibitor on determination of plasma thrombin generation in vitro.
    Lau A; Berry LR; Mitchell LG; Chan AK
    Thromb Res; 2007; 119(6):667-77. PubMed ID: 16793122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple activity assay for thrombin and hirudin.
    Dang QD; Di Cera E
    J Protein Chem; 1994 May; 13(4):367-73. PubMed ID: 7986342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of shortened platelet survival in rats by the antifibrinolytic agent, epsilon aminocaproic acid.
    Winocour PD; Kinlough-Rathbone RL; Richardson M; Mustard JF
    J Clin Invest; 1983 Jan; 71(1):159-64. PubMed ID: 6848557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin.
    Berry CN; Girardot C; Lecoffre C; Lunven C
    Thromb Haemost; 1994 Sep; 72(3):381-6. PubMed ID: 7855788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies on the inhibitory spectrum of recombinant hirudin, DuP 714 and heparin on thrombin and factor Xa generation in biochemically defined systems.
    Kaiser B; Callas D; Hoppensteadt D; Mallinowska K; Fareed J
    Thromb Res; 1994 Mar; 73(5):327-35. PubMed ID: 8016817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential.
    Hemker HC; Wielders S; Kessels H; Béguin S
    Thromb Haemost; 1993 Oct; 70(4):617-24. PubMed ID: 7509511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha 2-Macroglobulin remains as important as antithrombin III for thrombin regulation in cord plasma in the presence of endothelial cell surfaces.
    Ling X; Delorme M; Berry L; Ofosu F; Mitchell L; Paes B; Andrew M
    Pediatr Res; 1995 Mar; 37(3):373-8. PubMed ID: 7540283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of probenecid on the kinetics of epsilon-aminocaproic acid.
    Dvorchik BH; Katlic KL; Hayes AH; Eyster ME
    Clin Pharmacol Ther; 1980 Aug; 28(2):223-8. PubMed ID: 7398189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel immunoenzyme assays for thrombin-antithrombin III and thrombin-alpha 2-macroglobulin complexes in plasma.
    Harpel PC; Fenton JW
    Ann N Y Acad Sci; 1986; 485():184-98. PubMed ID: 2436524
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombin inhibition is impaired in plasma of sick neonates.
    Shah JK; Mitchell LG; Paes B; Ofosu FA; Schmidt B; Andrew M
    Pediatr Res; 1992 Apr; 31(4 Pt 1):391-5. PubMed ID: 1373886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hirudin for diagnostic purposes.
    Stocker K
    Haemostasis; 1991; 21 Suppl 1():161-7. PubMed ID: 1894191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.